Bayer Spin-Off AiCuris Licenses Phase III-Ready Antiviral to Merck & Co.
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 11 (Table of Contents)
Published: 5 Nov-2012
DOI: 10.3833/pdr.v2012.i11.1829 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Merck & Co...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS